Cannabidiol with clobazam
Central nervous system
1.1 Cannabidiol with clobazam is recommended as an option for treating seizures associated with Dravet syndrome in people aged 2 years and older, only if:
• the frequency of convulsive seizures is checked every 6 months, and cannabidiol is stopped if the frequency has not fallen by at least 30% compared with the 6 months before starting treatment
• the company provides cannabidiol according to the commercial arrangement.
Reason for decision: